J.R.S. Oryx Pharmaceuticals Pvt Ltd - Company Profile

It is a pharma private limited company based in Karnal, Haryana, India, established in 1993.
1993 Karnal, Haryana, India Active
Last Updated:
Access Report
About J.R.S. Oryx Pharmaceuticals Pvt Ltd

J.R.S. Oryx Pharmaceuticals Pvt Ltd, a active private limited company, was established on 16 April 1993 in Karnal, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85110HR1993PTC031972. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.64 M.

It upholds a compliant status. Its leadership includes Surinder Pal (Director), Parveen Goyal (Director). Past directors included Nathi Ram Verma, Rattan Lal Sharma, Ravi Prakash. It holds ₹3.04 Cr open charges and ₹1.77 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 217& 218, Sector-3, Hsiidc, Industrial Area,, Karnal, Haryana, 132001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110HR1993PTC031972

  • Registration Number

    031972

  • Incorporation Date

    16 April 1993

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹2.64 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 2.64 M
  • Company Age 32 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 3.04 Cr
  • Satisfied Charges ₹ 1.77 Cr
  • Revenue Growth **** -20.75%
  • Profit Growth **** 3.22%
  • Ebitda **** 74.83%
  • Net Worth 68.97%
  • Total Assets **** 18.26%
Company report

J.R.S. Oryx Pharmaceuticals Pvt Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into J.R.S. Oryx Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at J.R.S. Oryx Pharmaceuticals Pvt Ltd?
Current Directors
Name Designation Appointment Date Status
Surinder Pal Director 26 Apr 1993 Current
Parveen Goyal Director 05 Feb 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2013 Past
Pramod Abcsdd Director 10 Feb 2025 Past
Pramod Abcsdd Director 22 Oct 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of J.R.S. Oryx Pharmaceuticals.

J.R.S. Oryx Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 20.75% decrease. The company also saw a slight improvement in profitability, with a 3.22% increase in profit. The company's net worth Soared by an impressive increase of 68.97%.

J.R.S. Oryx Pharmaceuticals revenue growth over time
J.R.S. Oryx Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -20.75%
*******
*******
*******
*******
Revenue from Operations
*******
 -20.80%
*******
*******
*******
*******
Total Assets
*******
 18.26%
*******
*******
*******
*******
Profit or Loss
*******
 3.22%
*******
*******
*******
*******
Net Worth
*******
 68.97%
*******
*******
*******
*******
EBITDA
*******
 74.83%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of J.R.S. Oryx Pharmaceuticals?

In 2021, J.R.S. Oryx Pharmaceuticals had a promoter holding of 88.95% and a public holding of 11.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹30,350,000.00

Satisfied Charges

₹17,650,000.00

Charges Breakdown by Lending Institutions
  • Others : 3.04 Cr
Latest Charge Details
Date Lender Amount Status
20 Apr 2018 Others ₹3.04 Cr Open
17 Sep 2020 Others ₹3.00 M Satisfied
09 Feb 2015 L & T Finance Limited ₹0.25 M Satisfied
18 Jun 2013 Capital First Limited ₹9.15 M Satisfied
26 May 2006 Bank Of Punjab Limited ₹2.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at J.R.S. Oryx Pharmaceuticals?

Unlock and access historical data on people associated with J.R.S. Oryx Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of J.R.S. Oryx Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J.R.S. Oryx Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on J.R.S. Oryx Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity J.R.S. Oryx Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Others of Rs. 30.35 M registered on 20 Apr 2018 with Charge ID 100215901 was modified on 29 Apr 2025. was documented.

  • Balance Sheet

    Progress on J.R.S. Oryx Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    Progress on Parveen Goyal was appointed as a Director was appointed as a Director on 05 Feb 2025 & has been associated with this company since 1 year 14 days . was documented.

  • Charges

    A charge registered on 17 Sep 2020 via Charge ID 100368825 with Others was fully satisfied on 16 Mar 2022. was recorded as a recent event.

  • Charges

    A charge registered on 09 Feb 2015 via Charge ID 10573551 with L & T Finance Limited was fully satisfied on 02 Feb 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of J.R.S. Oryx Pharmaceuticals Pvt Ltd?

The CIN of J.R.S. Oryx Pharmaceuticals Pvt Ltd is U85110HR1993PTC031972.

Where is J.R.S. Oryx Pharmaceuticals Pvt Ltd headquartered?

J.R.S. Oryx Pharmaceuticals Pvt Ltd is headquartered at 217& 218, Sector-3, Hsiidc, Industrial Area,, Karnal, Haryana, 132001.

When was J.R.S. Oryx Pharmaceuticals Pvt Ltd incorporated?

J.R.S. Oryx Pharmaceuticals Pvt Ltd was incorporated on 16 April 1993.

Who are the current directors of J.R.S. Oryx Pharmaceuticals Pvt Ltd?

The current directors of J.R.S. Oryx Pharmaceuticals Pvt Ltd are

What is the primary industry of J.R.S. Oryx Pharmaceuticals Pvt Ltd?

The primary industry of J.R.S. Oryx Pharmaceuticals Pvt Ltd is Manufacturing.

Is J.R.S. Oryx Pharmaceuticals Pvt Ltd a listed company?

J.R.S. Oryx Pharmaceuticals Pvt Ltd is unlisted.

What is the capital structure of J.R.S. Oryx Pharmaceuticals Pvt Ltd?

The authorized capital of J.R.S. Oryx Pharmaceuticals Pvt Ltd is ₹5.00 M, and the paid-up capital is ₹2.64 M.

What is the compliance status of J.R.S. Oryx Pharmaceuticals Pvt Ltd?

The compliance status of J.R.S. Oryx Pharmaceuticals Pvt Ltd is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available